Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Astrocyte Announces Initiation of an Extended Infusion Phase 1B Study of AST-004 for Stroke and Traumatic Brain Injuries
Astrocyte Pharmaceuticals, a drug discovery and development company advancing novel cerebroprotective therapeutics for patients with […]
NIH Awards $4.7M to Cohen Children’s Medical Center and The Feinstein Institutes to Study Nephrotic Syndrome in Children
The National Institutes of Health (NIH) has awarded Northwell Health’s Cohen Children’s Medical Center and […]
Abivax Appoints Marc de Garidel as Chief Executive Officer and Interim Board Chair
Abivax, a Phase 3 clinical-stage biotechnology company focused on developing therapeutics that modulate the immune […]
MOLLI Surgical Launches Breakthrough Products to Simplify Breast Cancer Surgery and Deliver a Better Patient Experience
MOLLI Surgical, the company that is pushing the boundaries of precision surgery for breast cancer, […]
Personalis Joins Top UK Cancer Research Organizations to Evaluate Earlier Cancer Recurrence Detection Through Groundbreaking Study
Personalis, Cancer Research UK’s Cancer Research Horizons, University College London (UCL), and the Francis Crick […]
Felix Raises $18M CDN to Scale On-Demand Treatment for Everyday Health
Felix, Canada’s leading provider of on-demand treatment for everyday health, announces it has completed its […]
SamaCare Welcomes Komodo Health CEO Arif Nathoo to Board of Directors
SamaCare, a prior authorization platform for physician-administered medications, is excited to announce the addition of […]
Bridgewest Group launches NovaCina, a New Sterile Injectable CDMO
Global private investment firm, Bridgewest Group, recognized for developing innovative companies in life sciences, software, […]
Boston Scientific Closes Acquisition of Apollo Endosurgery
Boston Scientific today announced the close of its acquisition of Apollo Endosurgery, a publicly traded […]
ECCMID 2023: Shionogi to Present Data Showing COVID-19 Symptom Recurrence is Not Associated with Ensitrelvir Treatment
Shionogi today announced that two late-breaking poster presentations featuring new results from the Phase 3 […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more